3D Structure Inspector
Structure Overview
Ligand Interactions

4HLW - Overview - 3D Structure Inspector

Atoms
Solvent
Spheres
Surface
Colour
Opacity
Texture
Background

LeftMouse Rotate
Shift+Left Scale
Ctrl+Left Translate
Click Select
+,− Clipping
r Reset view

AstexViewer™ Copyright (C) 1999-2007 Astex Therapeutics Ltd.
OpenAstexViewer Copyright (C) 2007-2014 Mike Hartshorn





Display Compound Structure Het Het Names Het Formula
17W
17W
2-[(2-phenoxyethyl)sulfanyl]-1H-benzimidazole
C15 H14 N2 O S
GOL
CRY
E422
GLYCERIN
GOL
Glycerin
Glycerol
Glycogelatin
Keybells
MONOCTANOIN COMPONENT D
Monoctanoin Component D
Nirolex
Ophthalgan
Optim
Osmoglyn
Procalamine
Senokot Direct Relief
Tixylix Baby
Tixylix Toddler
Waterhouse
GLYCEROL
C3 H8 O3
TES
AXIRON
Androderm
Androgel
Androgel 1%
Andropatch
Axiron
Delatestryl
Depo-Testadiol
Depo-Testosterone
Ditate-DS
Fortesta
Intrinsa
Striant
Striant SR
TES
TESTOPEL
TESTOSTERONE
Testim
Testim 1%
Testoderm
Testoderm tts
Testogel
Testopatch
Testopel
Testoral
Testosterone
Tostran
TESTOSTERONE
C19 H28 O2
SO4
SO4
SUL
SULFATE ION
O4 S
PDB Code4HLW
TitleTARGETING THE BINDING FUNCTION 3 (BF3) SITE OF THE HUMAN ANDROGEN RECEPTOR THROUGH VIRTUAL SCREENING. 2. DEVELOPMENT OF 2-((2- PHENOXYETHYL) THIO)-1H-BENZOIMIDAZOLE DERIVATIVES.
Deposition
Release
Last Modified
ObsoleteNo
ClassificationTRANSCRIPTION
Experiment TypeX-RAY DIFFRACTION
Space GroupP 21 21 21
Resol Range High2.5
Resol Range Low42.42
Pubmed Id23301637
Doi10.1021/JM3015712
PDB Chain4HLW_A (click to show/hide)